Cargando…

HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity

BACKGROUND: Hematological and neurological expressed 1 (HN1) is upregulated in many tumors, but the role of HN1 in breast cancer progression and its regulatory mechanism have not been well understood. METHODS: To study the role of HN1 in the initiation and progression of breast cancer, we examined H...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chen, Xu, Bingfei, Lu, Shi, Zhao, Ying, Liu, Pian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426009/
https://www.ncbi.nlm.nih.gov/pubmed/28490334
http://dx.doi.org/10.1186/s12943-017-0656-1
_version_ 1783235382757818368
author Zhang, Chen
Xu, Bingfei
Lu, Shi
Zhao, Ying
Liu, Pian
author_facet Zhang, Chen
Xu, Bingfei
Lu, Shi
Zhao, Ying
Liu, Pian
author_sort Zhang, Chen
collection PubMed
description BACKGROUND: Hematological and neurological expressed 1 (HN1) is upregulated in many tumors, but the role of HN1 in breast cancer progression and its regulatory mechanism have not been well understood. METHODS: To study the role of HN1 in the initiation and progression of breast cancer, we examined HN1 levels in breast cancer cells and tissues and analyzed the relationship between HN1 levels and patient survival. We used mammosphere formation assay, side population analysis, wound healing assay, transwell assay, soft agar formation assay, and xenografted tumor model to determine the effect of HN1 on the expansion of breast cancer stem cells, and the migration, invasion and tumorigenesis of breast cancer. To determine whether HN1 regulates MYC, we used quantitative real-time PCR and Western blot analysis to assess the expression of MYC and their targeted genes to determine the phenotype caused by knockdown of MYC in breast cancer cell with HN1 overexpression. RESULTS: In this study, we found that HN1 was upregulated in breast cancer tissues. Patients with high levels of HN1 expression had significantly shorter survival than those with low HN1 expression. In breast cancer cell line, ectopic overexpression of HN1 not only promoted the expansion of breast cancer stem cells, but also promoted cell migration, invasion, and tumorigenesis, while knockdown of HN1 reduced these effects. Furthermore, there was a positive correlation between MYC (also known as c-MYC) level and HN1 level, mechanism analysis suggested HN1 promoted the expression of MYC and its targeted genes like CDK4, CCND1, p21, CAV1, and SFRP1. Downregulation of MYC abrogated the effect of HN1 overexpression in breast cancer cell lines. CONCLUSION: Taken together, these data reveal that HN1 promotes the progression of breast cancer by upregulating MYC expression, and might be a therapeutic target for breast cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-017-0656-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5426009
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54260092017-05-12 HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity Zhang, Chen Xu, Bingfei Lu, Shi Zhao, Ying Liu, Pian Mol Cancer Research BACKGROUND: Hematological and neurological expressed 1 (HN1) is upregulated in many tumors, but the role of HN1 in breast cancer progression and its regulatory mechanism have not been well understood. METHODS: To study the role of HN1 in the initiation and progression of breast cancer, we examined HN1 levels in breast cancer cells and tissues and analyzed the relationship between HN1 levels and patient survival. We used mammosphere formation assay, side population analysis, wound healing assay, transwell assay, soft agar formation assay, and xenografted tumor model to determine the effect of HN1 on the expansion of breast cancer stem cells, and the migration, invasion and tumorigenesis of breast cancer. To determine whether HN1 regulates MYC, we used quantitative real-time PCR and Western blot analysis to assess the expression of MYC and their targeted genes to determine the phenotype caused by knockdown of MYC in breast cancer cell with HN1 overexpression. RESULTS: In this study, we found that HN1 was upregulated in breast cancer tissues. Patients with high levels of HN1 expression had significantly shorter survival than those with low HN1 expression. In breast cancer cell line, ectopic overexpression of HN1 not only promoted the expansion of breast cancer stem cells, but also promoted cell migration, invasion, and tumorigenesis, while knockdown of HN1 reduced these effects. Furthermore, there was a positive correlation between MYC (also known as c-MYC) level and HN1 level, mechanism analysis suggested HN1 promoted the expression of MYC and its targeted genes like CDK4, CCND1, p21, CAV1, and SFRP1. Downregulation of MYC abrogated the effect of HN1 overexpression in breast cancer cell lines. CONCLUSION: Taken together, these data reveal that HN1 promotes the progression of breast cancer by upregulating MYC expression, and might be a therapeutic target for breast cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-017-0656-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-05-11 /pmc/articles/PMC5426009/ /pubmed/28490334 http://dx.doi.org/10.1186/s12943-017-0656-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zhang, Chen
Xu, Bingfei
Lu, Shi
Zhao, Ying
Liu, Pian
HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity
title HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity
title_full HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity
title_fullStr HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity
title_full_unstemmed HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity
title_short HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity
title_sort hn1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing myc activity
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426009/
https://www.ncbi.nlm.nih.gov/pubmed/28490334
http://dx.doi.org/10.1186/s12943-017-0656-1
work_keys_str_mv AT zhangchen hn1contributestomigrationinvasionandtumorigenesisofbreastcancerbyenhancingmycactivity
AT xubingfei hn1contributestomigrationinvasionandtumorigenesisofbreastcancerbyenhancingmycactivity
AT lushi hn1contributestomigrationinvasionandtumorigenesisofbreastcancerbyenhancingmycactivity
AT zhaoying hn1contributestomigrationinvasionandtumorigenesisofbreastcancerbyenhancingmycactivity
AT liupian hn1contributestomigrationinvasionandtumorigenesisofbreastcancerbyenhancingmycactivity